EDGAR Verified
Primary Source · SEC.gov

Special Situations Life Sciences Fund LP

CIK 0001333549Fund Vehicle2025 vintage506(b), 3(c)(1)

Raised

$75M

Investors

112

Min Invest

$0

AltStreet Analysis

·

Generated from EDGAR primary sources

Special Situations Life Sciences Fund LP is a Delaware limited partnership filing under Rule 506(b) and Section 3(c)(1), managed by LS Advisers, LLC and AWM Investment Company Inc. This amended filing reports $75.3M raised from 112 investors. The fund operates in the longevity/biotech sector through a pooled investment vehicle structure.

This 506(b) private placement in longevity biotech shows a broad investor base of 112 accredited participants at an average commitment of approximately $673K. The 3(c)(1) exemption structure is standard for sub-100-investor private funds targeting life sciences opportunities, and the Delaware LP form is typical for institutional biotech vehicles.

Data Flags

related_personsTwo executive officers listed as entities (LS Advisers, LLC and AWM Investment Company Inc.) suggest co-management or advisory arrangement between multiple firms
generalAmendment filing but no first sale date disclosed; however, this is within normal bounds for an institutional fund with $75M+ raised

EDGAR Filing Data

Form D — Primary Source

View on SEC.gov
CIK Number0001333549
Entity NameSpecial Situations Life Sciences Fund LP
Exemption506(b), 3(c)(1)
First Sale Date
Filing DateJuly 22, 2025
Accession Number0001641172-25-020491
Total Amount Sold$75M
Total Investors112
Minimum Investment$0 (no stated minimum)
Securities TypeEquity, Pooled Investment Fund
State of IncorporationNot specified
Amendment CountOriginal filing only

Related Persons (Form D)

Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.

David Greenhouse

Executive Officer · New York, NY

Adam Stettner

Executive Officer · New York, NY

- LS Advisers, LLC

Executive Officer · New York, NY

- AWM Investment Company Inc.

Executive Officer · New York, NY

Is this your offering?

Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.

Data Methodology

Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.